Skip to content
10-Q

Quarterly Report

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. CBIH

0001683168-26-003012

← back to feed
Filed
Apr 16, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Apr 16, 2026 11.63B sh
Shares Diluted Q3 2026 · Feb 28, 2026 11.63B sh
Shares Diluted Q3 2026 · Feb 28, 2026 11.63B sh
Operating Cash Flow Q3 2026 · Feb 28, 2026 −$123.8K
Long Term Debt Q3 2026 · Feb 28, 2026 $249.5K
Long Term Debt Q3 2026 · May 31, 2025 $249.5K
Short Term Debt Q3 2026 · Feb 28, 2026 $14.59K
Short Term Debt Q3 2026 · May 31, 2025 $14.59K
Stockholders Equity Q3 2026 · Feb 28, 2026 −$1.47M
Stockholders Equity Q3 2026 · Nov 30, 2025 −$1.36M
Stockholders Equity Q3 2026 · Aug 31, 2025 −$1.25M
Stockholders Equity Q3 2026 · May 31, 2025 −$1.16M
Current Liabilities Q3 2026 · Feb 28, 2026 $1.22M
Current Liabilities Q3 2026 · May 31, 2025 $945.96K
Total Liabilities Q3 2026 · Feb 28, 2026 $1.47M
Total Liabilities Q3 2026 · May 31, 2025 $1.2M
Current Assets Q3 2026 · Feb 28, 2026 $1.54K
Current Assets Q3 2026 · May 31, 2025 $29.09K
Total Assets Q3 2026 · Feb 28, 2026 $1.54K
Total Assets Q3 2026 · May 31, 2025 $31.88K
Eps Diluted Q3 2026 · Feb 28, 2026 $0.00
Eps Diluted Q3 2026 · Feb 28, 2026 $0.00
Eps Basic Q3 2026 · Feb 28, 2026 $0.00
Eps Basic Q3 2026 · Feb 28, 2026 $0.00
Sga Expense Q3 2026 · Feb 28, 2026 $26.83K
Sga Expense Q3 2026 · Feb 28, 2026 $81.11K
Net Income Q3 2026 · Feb 28, 2026 −$103.93K
Net Income Q3 2026 · Feb 28, 2026 −$303.55K
Net Income Q3 2026 · Nov 30, 2025 −$116.97K
Net Income Q3 2026 · Aug 31, 2025 −$82.65K
Operating Income Q3 2026 · Feb 28, 2026 −$93.26K
Operating Income Q3 2026 · Feb 28, 2026 −$263.92K
Gross Profit Q3 2026 · Feb 28, 2026 $8.16K
Gross Profit Q3 2026 · Feb 28, 2026 $66.98K
Cost Of Revenue Q3 2026 · Feb 28, 2026 $3.05K
Cost Of Revenue Q3 2026 · Feb 28, 2026 $21.69K
Revenue Q3 2026 · Feb 28, 2026 $11.21K
Revenue Q3 2026 · Feb 28, 2026 $88.67K